Oct 13, 2025 05:29AM Barclays Starts Celldex Therapeutics (CLDX) at Underweight

Oct 2, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Sep 24, 2025 10:38AM Celldex (CLDX) Mentioned as Positive Again at Citron Research

Sep 19, 2025 10:16AM Increasing unusual call option volume: CDLX INFY VLY REKR LDI AQST UP BFLY

Aug 20, 2025 06:56AM Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Aug 20, 2025 06:45AM Cantor Fitzgerald Reiterates Overweight Rating on Celldex Therapeutics (CLDX)

Aug 20, 2025 06:28AM Celldex Therapeutics (CLDX) PT Lowered to $62 at Canaccord Genuity

Aug 20, 2025 06:03AM Celldex Therapeutics (CLDX) PT Lowered to $42 at H.C. Wainwright

Aug 20, 2025 05:58AM Celldex Therapeutics (CLDX) PT Lowered to $38 at Wells Fargo

Aug 7, 2025 04:12PM Celldex (CLDX) Tops Q2 EPS by 1c

Jun 16, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Jun 13, 2025 07:07AM Cantor Fitzgerald Reiterates Overweight Rating on Celldex Therapeutics (CLDX)

Jun 12, 2025 06:44AM Canaccord Genuity Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Jun 6, 2025 08:01AM Celldex (CLDX) Appoints Denice Torres to its Board

May 20, 2025 07:52AM Cantor Fitzgerald Reiterates Overweight Rating on Celldex Therapeutics (CLDX)

May 9, 2025 07:01AM Celldex Therapeutics (CLDX) PT Lowered to $50 at H.C. Wainwright

May 6, 2025 09:13AM Cantor Fitzgerald Reiterates Overweight Rating on Celldex Therapeutics (CLDX)

May 5, 2025 04:26PM Celldex (CLDX) Tops Q1 EPS by 3c

Mar 20, 2025 03:48AM Morgan Stanley Starts Celldex Therapeutics (CLDX) at Overweight

Mar 4, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Mar 3, 2025 08:05AM Celldex (CLDX) Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025

Feb 27, 2025 04:58PM Celldex (CLDX) Misses Q4 EPS by 2c

Jan 8, 2025 12:33PM Oppenheimer on Jasper (JSPR): 'adding cohorts and remains on track to begin a registrational program in CSU with a Ph2b study expected to initiate in 2H25'

Jan 8, 2025 12:18PM Guggenheim on Celldex Therapeutics (CLDX): 'CLDX Remains Leader In The Mast Cell Space'

Jan 8, 2025 12:03PM Stifel on Celldex (CLDX) and Third Harmonic Bio (THRD): 'we continue to like the prospects of CLDX and THRD as both first-in-class and an oral pure-play'

Jan 8, 2025 12:00PM Citi on Celldex Therapeutics (CLDX): 'Competitor CSU Data Unclear Under the Surface; Positive Readthrough for Celldex'

Nov 20, 2024 07:24AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Nov 6, 2024 04:04PM Celldex (CLDX) Tops Q3 EPS by 3c

Oct 29, 2024 07:25AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Oct 28, 2024 02:24PM TD Cowen Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Oct 15, 2024 05:50AM Goldman Sachs Reiterates Neutral Rating on Celldex Therapeutics (CLDX)

Oct 7, 2024 03:39AM Citi Starts Celldex Therapeutics (CLDX) at Buy

Sep 30, 2024 04:18AM Goldman Sachs Starts Celldex Therapeutics (CLDX) at Neutral

Sep 27, 2024 07:23AM TD Cowen Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Sep 26, 2024 07:24AM Leerink Partners Reiterates Outperform Rating on Celldex Therapeutics (CLDX)

Sep 26, 2024 06:28AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Sep 25, 2024 04:01PM Guggenheim on Celldex Therapeutics (CLDX): 'We continue to think today's stock reaction is overdone'

Sep 25, 2024 02:33PM Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Sep 25, 2024 11:02AM Celldex (CLDX) Halted on Volatility, Down 21% Following 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria

Sep 25, 2024 10:45AM Celldex (CLDX) Presents Landmark 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV 2024

Aug 8, 2024 06:12PM Celldex (CLDX) Tops Q2 EPS by 5c

Jul 29, 2024 04:59PM Celldex (CLDX) Presents Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria

Jul 16, 2024 08:02AM Celldex (CLDX) Initiates Global Phase 3 Program for Barzolvolimab

Jun 17, 2024 04:07PM Stifel Starts Celldex Therapeutics (CLDX) at Buy

Jun 11, 2024 05:00AM Wolfe Research Starts Celldex Therapeutics (CLDX) at Outperform